SGHT logo

Sight Sciences Inc. (SGHT)

$10.49

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SGHT

Market cap

$583023469

EPS

-0.51

P/E ratio

--

Price to sales

5.87

Dividend yield

--

Beta

2.430968

Price on SGHT

Previous close

$10.59

Today's open

$10.50

Day's range

$10.32 - $10.69

52 week range

$3.38 - $11.60

Profile about SGHT

CEO

Paul Badawi

Employees

186

Headquarters

Menlo Park, CA

Exchange

Nasdaq Global Select

Shares outstanding

55578977

Issue type

Common Stock

SGHT industries and sectors

Healthcare

Medical Equipment & Supplies

News on SGHT

Sight Sciences, Inc. (SGHT) is a Great Momentum Stock: Should You Buy?

Does Sight Sciences, Inc. (SGHT) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Nov 12, 2026

news preview

What Sight Sciences (SGHT) Said on Its Q3 Earnings Call

Sight Sciences NASDAQ: SGHT raised its full-year revenue outlook after reporting record third-quarter sales, driven by growth in its glaucoma business and increased adoption of its TearCare dry eye treatment.

news source

MarketBeat • Nov 5, 2026

news preview

Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, announced today that the Centers for Medicare & Medicaid Services (CMS) has established a new direct practice expense supply code for the single-use TearCare SmartLids® component of the TearCare® System (TearCare).

news source

GlobeNewsWire • Nov 5, 2026

news preview

Sight Sciences to Present at Two Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced plans to present at two upcoming conferences.

news source

GlobeNewsWire • Nov 5, 2026

news preview

Sight Sciences, Inc. (SGHT) Q3 2026 Earnings Call Transcript

Sight Sciences, Inc. (SGHT) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the third quarter ended September 30, 2026.

news source

GlobeNewsWire • Nov 4, 2026

news preview

Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.16 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Should You Buy?

Sight Sciences (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Oct 28, 2026

news preview

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

MENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the third quarter ended September 30, 2026, after the market close on Wednesday, November 4, 2026. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

news source

GlobeNewsWire • Oct 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Sight Sciences Inc.

Open an M1 investment account to buy and sell Sight Sciences Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SGHT on M1